{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:45:50Z","timestamp":1791355550371,"version":"4.3.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"7-8","license":[{"start":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T00:00:00Z","timestamp":1713052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T00:00:00Z","timestamp":1713052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100013254","name":"National College Students Innovation and Entrepreneurship Training Program","doi-asserted-by":"publisher","award":["S202310403066"],"award-info":[{"award-number":["S202310403066"]}],"id":[{"id":"10.13039\/501100013254","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160371"],"award-info":[{"award-number":["82160371"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100869"],"award-info":[{"award-number":["82100869"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20212BAB216051"],"award-info":[{"award-number":["20212BAB216051"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20212BAB216047"],"award-info":[{"award-number":["20212BAB216047"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022957","name":"Double Thousand Plan of Jiangxi Province","doi-asserted-by":"publisher","award":["jxsq2023201105"],"award-info":[{"award-number":["jxsq2023201105"]}],"id":[{"id":"10.13039\/100022957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s10495-024-01960-7","type":"journal-article","created":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T12:01:22Z","timestamp":1713096082000},"page":"1070-1089","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Exploring a specialized programmed-cell death patterns to predict the prognosis and sensitivity of immunotherapy in cutaneous melanoma via machine learning"],"prefix":"10.1007","volume":"29","author":[{"given":"Leyang","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifeng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaibo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gelin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengye","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deju","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,14]]},"reference":[{"key":"1960_CR1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(23)00821-8","volume":"402","author":"GV Long","year":"2023","unstructured":"Long GV, Swetter SM, Menzies AM, Gershenwald JE, Scolyer RA (2023) Cutaneous melanoma. Lancet 402:485\u2013502","journal-title":"Lancet"},{"key":"1960_CR2","first-page":"1071","volume":"52","author":"GC Leonardi","year":"2018","unstructured":"Leonardi GC, Falzone L, Salemi R, Zanghi A, Spandidos DA, McCubrey JA, Candido S, Libra M (2018) Cutaneous melanoma: From pathogenesis to therapy (Review). Int J Oncol 52:1071\u20131080","journal-title":"Int J Oncol"},{"key":"1960_CR3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","volume":"158","author":"M Arnold","year":"2022","unstructured":"Arnold M, Singh D, Laversanne M, Vignat J, Vaccarella S, Meheus F, Cust AE, de Vries E, Whiteman DC, Bray F (2022) Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040. JAMA Dermatol 158:495\u2013503","journal-title":"JAMA Dermatol"},{"key":"1960_CR4","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejpb.2023.02.002","volume":"184","author":"I Pereira","year":"2023","unstructured":"Pereira I, Monteiro C, Pereira-Silva M, Peixoto D, Nunes C, Reis S, Veiga F, Hamblin MR, Paiva-Santos AC (2023) Nanodelivery systems for cutaneous melanoma treatment. Eur J Pharm Biopharm 184:214\u2013247","journal-title":"Eur J Pharm Biopharm"},{"key":"1960_CR5","doi-asserted-by":"publisher","unstructured":"Rizzetto G, Lucarini G, De Simoni E, Molinelli E, Mattioli-Belmonte M, Offidani A, Simonetti O (2022) Tissue Biomarkers Predicting Lymph Node Status in Cutaneous Melanoma. Int J Mol Sci 24(1):144. https:\/\/doi.org\/10.3390\/ijms24010144","DOI":"10.3390\/ijms24010144"},{"key":"1960_CR6","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","volume":"17","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhang Z (2020) The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol 17:807\u2013821","journal-title":"Cell Mol Immunol"},{"key":"1960_CR7","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","volume":"19","author":"A Chow","year":"2022","unstructured":"Chow A, Perica K, Klebanoff CA, Wolchok JD (2022) Clinical implications of T cell exhaustion for cancer immunotherapy. Nat Rev Clin Oncol 19:775\u2013790","journal-title":"Nat Rev Clin Oncol"},{"key":"1960_CR8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-018-0142-8","volume":"16","author":"JS O'Donnell","year":"2019","unstructured":"O\u2019Donnell JS, Teng MWL, Smyth MJ (2019) Cancer immunoediting and resistance to T cell-based immunotherapy. Nat Rev Clin Oncol 16:151\u2013167","journal-title":"Nat Rev Clin Oncol"},{"key":"1960_CR9","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3892\/ijo.2020.5088","volume":"57","author":"GC Leonardi","year":"2020","unstructured":"Leonardi GC, Candido S, Falzone L, Spandidos DA, Libra M (2020) Cutaneous melanoma and the immunotherapy revolution (Review). Int J Oncol 57:609\u2013618","journal-title":"Int J Oncol"},{"key":"1960_CR10","doi-asserted-by":"crossref","first-page":"847345","DOI":"10.3389\/fimmu.2022.847345","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu J, Hong M, Li Y, Chen D, Wu Y, Hu Y (2022) Programmed Cell Death Tunes Tumor Immunity. Front Immunol 13:847345","journal-title":"Front Immunol"},{"key":"1960_CR11","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41580-020-0270-8","volume":"21","author":"S Bedoui","year":"2020","unstructured":"Bedoui S, Herold MJ, Strasser A (2020) Emerging connectivity of programmed cell death pathways and its physiological implications. Nat Rev Mol Cell Biol 21:678\u2013695","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1960_CR12","doi-asserted-by":"crossref","first-page":"106936","DOI":"10.1016\/j.ijsu.2022.106936","volume":"107","author":"Y Zou","year":"2022","unstructured":"Zou Y, Xie J, Zheng S, Liu W, Tang Y, Tian W, Deng X, Wu L, Zhang Y, Wong CW et al (2022) Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery. Int J Surg 107:106936","journal-title":"Int J Surg"},{"key":"1960_CR13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-015-0321-5","volume":"14","author":"Z Su","year":"2015","unstructured":"Su Z, Yang Z, Xu Y, Chen Y, Yu Q (2015) Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol Cancer 14:48","journal-title":"Mol Cancer"},{"key":"1960_CR14","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/s43018-021-00282-w","volume":"2","author":"Z Hu","year":"2021","unstructured":"Hu Z, Yuan J, Long M, Jiang J, Zhang Y, Zhang T, Xu M, Fan Y, Tanyi JL, Montone KT et al (2021) The Cancer Surfaceome Atlas integrates genomic, functional and drug response data to identify actionable targets. Nat Cancer 2:1406\u20131422","journal-title":"Nat Cancer"},{"key":"1960_CR15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar R, Domrachev M, Lash AE (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30:207\u2013210","journal-title":"Nucleic Acids Res"},{"key":"1960_CR16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.gpb.2022.08.004","volume":"21","author":"Z Chen","year":"2023","unstructured":"Chen Z, Luo Z, Zhang D, Li H, Liu X, Zhu K, Zhang H, Wang Z, Zhou P, Ren J et al (2023) TIGER: A Web Portal of Tumor Immunotherapy Gene Expression Resource. Genomics Proteomics Bioinformatics 21:337\u2013348","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"1960_CR17","doi-asserted-by":"publisher","unstructured":"Li J, Miao B, Wang S, Dong W, Xu H, Si C, Wang W, Duan S, Lou J, Bao Z, Zeng H, Yang Z, Cheng W, Zhao F, Zeng J, Liu XS, Wu R, Shen Y, Chen Z, Chen S, Wang M (2022) Hiplot: a comprehensive and easy-to-use web service for boosting publication-ready biomedical data visualization. Brief Bioinform 23(4):bbac261. https:\/\/doi.org\/10.1093\/bib\/bbac261","DOI":"10.1093\/bib\/bbac261"},{"key":"1960_CR18","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","volume":"29","author":"D Tang","year":"2019","unstructured":"Tang D, Kang R, Berghe TV, Vandenabeele P, Kroemer G (2019) The molecular machinery of regulated cell death. Cell Res 29:347\u2013364","journal-title":"Cell Res"},{"key":"1960_CR19","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","volume":"25","author":"X Liu","year":"2023","unstructured":"Liu X, Nie L, Zhang Y, Yan Y, Wang C, Colic M, Olszewski K, Horbath A, Chen X, Lei G et al (2023) Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. Nat Cell Biol 25:404\u2013414","journal-title":"Nat Cell Biol"},{"key":"1960_CR20","doi-asserted-by":"crossref","first-page":"896099","DOI":"10.3389\/fmolb.2022.896099","volume":"9","author":"S Mustafa","year":"2022","unstructured":"Mustafa S, Koran S, AlOmair L (2022) Insights Into the Role of Matrix Metalloproteinases in Cancer and its Various Therapeutic Aspects: A Review. Front Mol Biosci 9:896099","journal-title":"Front Mol Biosci"},{"key":"1960_CR21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann S, Castelo R, Guinney J (2013) GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform 14:7","journal-title":"BMC Bioinform"},{"key":"1960_CR22","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1111\/j.1365-2702.2011.04023.x","volume":"21","author":"R Flynn","year":"2012","unstructured":"Flynn R (2012) Survival analysis. J Clin Nurs 21:2789\u20132797","journal-title":"J Clin Nurs"},{"key":"1960_CR23","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN (2010) ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics 26:1572\u20131573","journal-title":"Bioinformatics"},{"key":"1960_CR24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13073-020-0721-z","volume":"12","author":"J Fu","year":"2020","unstructured":"Fu J, Li K, Zhang W, Wan C, Zhang J, Jiang P, Liu XS (2020) Large-scale public data reuse to model immunotherapy response and resistance. Genome Med 12:21","journal-title":"Genome Med"},{"key":"1960_CR25","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E et al (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2:401\u2013404","journal-title":"Cancer Discov"},{"key":"1960_CR26","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP (2018) Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res 28:1747\u20131756","journal-title":"Genome Res"},{"key":"1960_CR27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12967-023-03891-4","volume":"21","author":"D Liu","year":"2023","unstructured":"Liu D, Yang F, Zhang T, Mao R (2023) Leveraging a cuproptosis-based signature to predict the prognosis and drug sensitivity of cutaneous melanoma. J Transl Med 21:57","journal-title":"J Transl Med"},{"key":"1960_CR28","doi-asserted-by":"crossref","first-page":"687975","DOI":"10.3389\/fimmu.2021.687975","volume":"12","author":"D Zeng","year":"2021","unstructured":"Zeng D, Ye Z, Shen R, Yu G, Wu J, Xiong Y, Zhou R, Qiu W, Huang N, Sun L et al (2021) IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures. Front Immunol 12:687975","journal-title":"Front Immunol"},{"issue":"3573\u20133587","key":"1960_CR29","first-page":"e3529","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E, Mauck WM 3rd, Zheng S, Butler A, Lee MJ, Wilk AJ, Darby C, Zager M et al (2021) Integrated analysis of multimodal single-cell data. Cell 184(3573\u20133587):e3529","journal-title":"Cell"},{"key":"1960_CR30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12943-023-01791-1","volume":"22","author":"H Fang","year":"2023","unstructured":"Fang H, Sun Q, Zhou J, Zhang H, Song Q, Zhang H, Yu G, Guo Y, Huang C, Mou Y et al (2023) m(6)A methylation reader IGF2BP2 activates endothelial cells to promote angiogenesis and metastasis of lung adenocarcinoma. Mol Cancer 22:99","journal-title":"Mol Cancer"},{"key":"1960_CR31","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/neuonc\/noad017","volume":"25","author":"Z Wang","year":"2023","unstructured":"Wang Z, Wang Y, Chang M, Wang Y, Liu P, Wu J, Wang G, Tang X, Hui X, Liu P et al (2023) Single-cell transcriptomic analyses provide insights into the cellular origins and drivers of brain metastasis from lung adenocarcinoma. Neuro Oncol 25:1262\u20131274","journal-title":"Neuro Oncol"},{"key":"1960_CR32","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK (2015) limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43:e47","journal-title":"Nucleic Acids Res"},{"key":"1960_CR33","doi-asserted-by":"publisher","unstructured":"Hu K, He R, Xu M, Zhang D, Han G, Han S, Xiao L, Xia P, Ling J, Wu T, Li F, Sheng Y, Zhang J, Yu P (2023) Identification of necroptosis-related features in diabetic nephropathy and analysis of their immune microenvironent and inflammatory response.\u00a0Front Cell Dev Biol 11:1271145. https:\/\/doi.org\/10.3389\/fcell.2023.1271145","DOI":"10.3389\/fcell.2023.1271145"},{"key":"1960_CR34","doi-asserted-by":"crossref","first-page":"D1049","DOI":"10.1093\/nar\/gku1179","volume":"43","author":"C Gene Ontology","year":"2015","unstructured":"Gene Ontology C (2015) Gene Ontology Consortium: going forward. Nucleic Acids Res 43:D1049-1056","journal-title":"Nucleic Acids Res"},{"key":"1960_CR35","doi-asserted-by":"crossref","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K (2017) KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res 45:D353\u2013D361","journal-title":"Nucleic Acids Res"},{"key":"1960_CR36","doi-asserted-by":"crossref","first-page":"W60","DOI":"10.1093\/nar\/gky311","volume":"46","author":"M Franz","year":"2018","unstructured":"Franz M, Rodriguez H, Lopes C, Zuberi K, Montojo J, Bader GD, Morris Q (2018) GeneMANIA update 2018. Nucleic Acids Res 46:W60\u2013W64","journal-title":"Nucleic Acids Res"},{"key":"1960_CR37","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41467-022-28421-6","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu Z, Liu L, Weng S, Guo C, Dang Q, Xu H, Wang L, Lu T, Zhang Y, Sun Z, Han X (2022) Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer. Nat Commun 13:816","journal-title":"Nat Commun"},{"key":"1960_CR38","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s13167-023-00327-3","volume":"14","author":"J Liu","year":"2023","unstructured":"Liu J, Shi Y, Zhang Y (2023) Multi-omics identification of an immunogenic cell death-related signature for clear cell renal cell carcinoma in the context of 3P medicine and based on a 101-combination machine learning computational framework. EPMA J 14:275\u2013305","journal-title":"EPMA J"},{"key":"1960_CR39","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cmpb.2019.05.028","volume":"177","author":"D Kong","year":"2019","unstructured":"Kong D, Zhu J, Wu S, Duan C, Lu L, Chen D (2019) A novel IRBF-RVM model for diagnosis of atrial fibrillation. Comput Methods Programs Biomed 177:183\u2013192","journal-title":"Comput Methods Programs Biomed"},{"issue":"984\u2013997","key":"1960_CR40","first-page":"e924","volume":"175","author":"L Jerby-Arnon","year":"2018","unstructured":"Jerby-Arnon L, Shah P, Cuoco MS, Rodman C, Su MJ, Melms JC, Leeson R, Kanodia A, Mei S, Lin JR et al (2018) A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade. Cell 175(984\u2013997):e924","journal-title":"Cell"},{"key":"1960_CR41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cmpb.2018.10.020","volume":"168","author":"T Emura","year":"2019","unstructured":"Emura T, Matsui S, Chen HY (2019) compound. Cox: Univariate feature selection and compound covariate for predicting survival. Comput Methods Programs Biomed 168:21\u201337","journal-title":"Comput Methods Programs Biomed"},{"key":"1960_CR42","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","volume":"26","author":"A Iasonos","year":"2008","unstructured":"Iasonos A, Schrag D, Raj GV, Panageas KS (2008) How to build and interpret a nomogram for cancer prognosis. J Clin Oncol 26:1364\u20131370","journal-title":"J Clin Oncol"},{"key":"1960_CR43","doi-asserted-by":"crossref","first-page":"D955","DOI":"10.1093\/nar\/gks1111","volume":"41","author":"W Yang","year":"2013","unstructured":"Yang W, Soares J, Greninger P, Edelman EJ, Lightfoot H, Forbes S, Bindal N, Beare D, Smith JA, Thompson IR et al (2013) Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res 41:D955-961","journal-title":"Nucleic Acids Res"},{"key":"1960_CR44","doi-asserted-by":"publisher","unstructured":"Maeser D, Gruener RF, Huang RS (2021) oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform 22(6):bbab260. https:\/\/doi.org\/10.1093\/bib\/bbab260","DOI":"10.1093\/bib\/bbab260"},{"key":"1960_CR45","doi-asserted-by":"crossref","first-page":"656364","DOI":"10.3389\/fimmu.2021.656364","volume":"12","author":"K Khalaf","year":"2021","unstructured":"Khalaf K, Hana D, Chou JT, Singh C, Mackiewicz A, Kaczmarek M (2021) Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance. Front Immunol 12:656364","journal-title":"Front Immunol"},{"key":"1960_CR46","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.7150\/ijbs.72534","volume":"18","author":"A Zhang","year":"2022","unstructured":"Zhang A, Miao K, Sun H, Deng CX (2022) Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance. Int J Biol Sci 18:3019\u20133033","journal-title":"Int J Biol Sci"},{"key":"1960_CR47","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrclinonc.2017.43","volume":"14","author":"JJ Luke","year":"2017","unstructured":"Luke JJ, Flaherty KT, Ribas A, Long GV (2017) Targeted agents and immunotherapies: optimizing outcomes in melanoma. Nat Rev Clin Oncol 14:463\u2013482","journal-title":"Nat Rev Clin Oncol"},{"issue":"845\u2013865","key":"1960_CR48","first-page":"e847","volume":"39","author":"A Bagaev","year":"2021","unstructured":"Bagaev A, Kotlov N, Nomie K, Svekolkin V, Gafurov A, Isaeva O, Osokin N, Kozlov I, Frenkel F, Gancharova O et al (2021) Conserved pan-cancer microenvironment subtypes predict response to immunotherapy. Cancer Cell 39(845\u2013865):e847","journal-title":"Cancer Cell"},{"key":"1960_CR49","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12943-020-01290-7","volume":"19","author":"R Ballotti","year":"2020","unstructured":"Ballotti R, Cheli Y, Bertolotto C (2020) The complex relationship between MITF and the immune system: a Melanoma ImmunoTherapy (response) Factor? Mol Cancer 19:170","journal-title":"Mol Cancer"},{"key":"1960_CR50","doi-asserted-by":"crossref","first-page":"939978","DOI":"10.3389\/fimmu.2022.939978","volume":"13","author":"Y Sha","year":"2022","unstructured":"Sha Y, Jiang R, Miao Y, Qin S, Wu W, Xia Y, Wang L, Fan L, Jin H, Xu W et al (2022) The pyroptosis-related gene signature predicts prognosis and indicates the immune microenvironment status of chronic lymphocytic leukemia. Front Immunol 13:939978","journal-title":"Front Immunol"},{"key":"1960_CR51","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1186\/s12967-023-04468-x","volume":"21","author":"H Qin","year":"2023","unstructured":"Qin H, Abulaiti A, Maimaiti A, Abulaiti Z, Fan G, Aili Y, Ji W, Wang Z, Wang Y (2023) Integrated machine learning survival framework develops a prognostic model based on inter-crosstalk definition of mitochondrial function and cell death patterns in a large multicenter cohort for lower-grade glioma. J Transl Med 21:588","journal-title":"J Transl Med"},{"key":"1960_CR52","doi-asserted-by":"crossref","first-page":"685377","DOI":"10.3389\/fonc.2021.685377","volume":"11","author":"J Yu","year":"2021","unstructured":"Yu J, Wang Q, Zhang X, Guo Z, Cui X (2021) Mechanisms of Neoantigen-Targeted Induction of Pyroptosis and Ferroptosis: From Basic Research to Clinical Applications. Front Oncol 11:685377","journal-title":"Front Oncol"},{"key":"1960_CR53","doi-asserted-by":"crossref","first-page":"120832","DOI":"10.1016\/j.lfs.2022.120832","volume":"307","author":"J Zhong","year":"2022","unstructured":"Zhong J, Wang Z, Houssou Hounye A, Liu J, Zhang J, Qi M (2022) A novel pyroptosis-related LncRNA signature predicts prognosis and indicates tumor immune microenvironment in skin cutaneous melanoma. Life Sci 307:120832","journal-title":"Life Sci"},{"key":"1960_CR54","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12864-022-08475-y","volume":"23","author":"Y Chen","year":"2022","unstructured":"Chen Y, Guo L, Zhou Z, An R, Wang J (2022) Identification and validation of a prognostic model for melanoma patients with 9 ferroptosis-related gene signature. BMC Genomics 23:245","journal-title":"BMC Genomics"},{"key":"1960_CR55","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.semcancer.2019.10.002","volume":"60","author":"Y Verhoeven","year":"2020","unstructured":"Verhoeven Y, Tilborghs S, Jacobs J, De Waele J, Quatannens D, Deben C, Prenen H, Pauwels P, Trinh XB, Wouters A et al (2020) The potential and controversy of targeting STAT family members in cancer. Semin Cancer Biol 60:41\u201356","journal-title":"Semin Cancer Biol"},{"key":"1960_CR56","doi-asserted-by":"crossref","first-page":"108189","DOI":"10.1016\/j.pharmthera.2022.108189","volume":"239","author":"A Cirella","year":"2022","unstructured":"Cirella A, Luri-Rey C, Di Trani CA, Teijeira A, Olivera I, Bolanos E, Castanon E, Palencia B, Brocco D, Fernandez-Sendin M et al (2022) Novel strategies exploiting interleukin-12 in cancer immunotherapy. Pharmacol Ther 239:108189","journal-title":"Pharmacol Ther"},{"key":"1960_CR57","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1089\/104303402760293547","volume":"13","author":"AK Behera","year":"2002","unstructured":"Behera AK, Kumar M, Lockey RF, Mohapatra SS (2002) Adenovirus-mediated interferon gamma gene therapy for allergic asthma: involvement of interleukin 12 and STAT4 signaling. Hum Gene Ther 13:1697\u20131709","journal-title":"Hum Gene Ther"},{"key":"1960_CR58","doi-asserted-by":"crossref","first-page":"107709","DOI":"10.1016\/j.pharmthera.2020.107709","volume":"219","author":"T Tang","year":"2021","unstructured":"Tang T, Cheng X, Truong B, Sun L, Yang X, Wang H (2021) Molecular basis and therapeutic implications of CD40\/CD40L immune checkpoint. Pharmacol Ther 219:107709","journal-title":"Pharmacol Ther"},{"key":"1960_CR59","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1600-065X.2008.00644.x","volume":"223","author":"M Pesu","year":"2008","unstructured":"Pesu M, Laurence A, Kishore N, Zwillich SH, Chan G, O\u2019Shea JJ (2008) Therapeutic targeting of Janus kinases. Immunol Rev 223:132\u2013142","journal-title":"Immunol Rev"},{"key":"1960_CR60","doi-asserted-by":"publisher","unstructured":"Waite JC, Wang B, Haber L, Hermann A, Ullman E, Ye X, Dudgeon D, Slim R, Ajithdoss DK, Godin SJ, Ramos I, Wu Q, Oswald E, Poon P, Golubov J, Grote D, Stella J, Pawashe A, Finney J, Herlihy E, Ahmed H, Kamat V, Dorvilliers A, Navarro E, Xiao J, Kim J, Yang SN, Warsaw J, Lett C, Canova L, Schulenburg T, Foster R, Krueger P, Garnova E, Rafique A, Babb R, Chen G, Stokes Oristian N, Siao CJ, Daly C, Gurer C, Martin J, Macdonald L, MacDonald D, Poueymirou W, Smith E, Lowy I, Thurston G, Olson W, Lin JC, Sleeman MA, Yancopoulos GD, Murphy AJ, Skokos D (2020) Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapy. Sci Transl Med 12(549):eaba2325. https:\/\/doi.org\/10.1126\/scitranslmed.aba2325","DOI":"10.1126\/scitranslmed.aba2325"},{"key":"1960_CR61","doi-asserted-by":"crossref","first-page":"651634","DOI":"10.3389\/fimmu.2021.651634","volume":"12","author":"M Khan","year":"2021","unstructured":"Khan M, Arooj S, Wang H (2021) Soluble B7-CD28 Family Inhibitory Immune Checkpoint Proteins and Anti-Cancer Immunotherapy. Front Immunol 12:651634","journal-title":"Front Immunol"},{"key":"1960_CR62","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1158\/1078-0432.CCR-06-2430","volume":"13","author":"JA Barnett","year":"2007","unstructured":"Barnett JA, Urbauer DL, Murray GI, Fuller GN, Heimberger AB (2007) Cytochrome P450 1B1 expression in glial cell tumors: an immunotherapeutic target. Clin Cancer Res 13:3559\u20133567","journal-title":"Clin Cancer Res"},{"key":"1960_CR63","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1158\/1078-0432.CCR-04-2111","volume":"11","author":"JG Gribben","year":"2005","unstructured":"Gribben JG, Ryan DP, Boyajian R, Urban RG, Hedley ML, Beach K, Nealon P, Matulonis U, Campos S, Gilligan TD et al (2005) Unexpected association between induction of immunity to the universal tumor antigen CYP1B1 and response to next therapy. Clin Cancer Res 11:4430\u20134436","journal-title":"Clin Cancer Res"},{"issue":"792\u2013809","key":"1960_CR64","first-page":"e723","volume":"184","author":"S Cheng","year":"2021","unstructured":"Cheng S, Li Z, Gao R, Xing B, Gao Y, Yang Y, Qin S, Zhang L, Ouyang H, Du P et al (2021) A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell 184(792\u2013809):e723","journal-title":"Cell"},{"key":"1960_CR65","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/cac2.12486","volume":"43","author":"X Qu","year":"2023","unstructured":"Qu X, Wang Y, Jiang Q, Ren T, Guo C, Hua K, Qiu J (2023) Interactions of Indoleamine 2,3-dioxygenase-expressing LAMP3(+) dendritic cells with CD4(+) regulatory T cells and CD8(+) exhausted T cells: synergistically remodeling of the immunosuppressive microenvironment in cervical cancer and therapeutic implications. Cancer Commun (Lond) 43:1207\u20131228","journal-title":"Cancer Commun (Lond)"},{"key":"1960_CR66","doi-asserted-by":"crossref","first-page":"1000652","DOI":"10.3389\/fgene.2022.1000652","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu Z, Qi Y, Wang H, Zhang Q, Wu Z, Wu W (2022) Risk model of hepatocellular carcinoma based on cuproptosis-related genes. Front Genet 13:1000652","journal-title":"Front Genet"},{"key":"1960_CR67","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1084\/jem.20110675","volume":"209","author":"C Wang","year":"2012","unstructured":"Wang C, McPherson AJ, Jones RB, Kawamura KS, Lin GH, Lang PA, Ambagala T, Pellegrini M, Calzascia T, Aidarus N et al (2012) Loss of the signaling adaptor TRAF1 causes CD8+ T cell dysregulation during human and murine chronic infection. J Exp Med 209:77\u201391","journal-title":"J Exp Med"},{"key":"1960_CR68","doi-asserted-by":"publisher","unstructured":"Li G, Boucher JC, Kotani H, Park K, Zhang Y, Shrestha B, Wang X, Guan L, Beatty N, Abate-Daga D, Davila ML (2018) 4-1BB enhancement of CAR T function requires NF-\u03baB and TRAFs. JCI Insight 3(18):e121322. https:\/\/doi.org\/10.1172\/jci.insight.121322","DOI":"10.1172\/jci.insight.121322"},{"key":"1960_CR69","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1056\/NEJMoa1408868","volume":"371","author":"J Larkin","year":"2014","unstructured":"Larkin J, Ascierto PA, Dreno B, Atkinson V, Liszkay G, Maio M, Mandala M, Demidov L, Stroyakovskiy D, Thomas L et al (2014) Combined vemurafenib and cobimetinib in BRAF-mutated melanoma. N Engl J Med 371:1867\u20131876","journal-title":"N Engl J Med"},{"key":"1960_CR70","first-page":"488","volume":"23","author":"S Bhatia","year":"2009","unstructured":"Bhatia S, Tykodi SS, Thompson JA (2009) Treatment of metastatic melanoma: an overview. Oncology (Williston Park) 23:488\u2013496","journal-title":"Oncology (Williston Park)"},{"key":"1960_CR71","doi-asserted-by":"crossref","first-page":"108344","DOI":"10.1016\/j.intimp.2021.108344","volume":"101","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Zhang C, Zhang J, Han D, Shi X (2021) Comprehensive analysis of the prognosis and biological significance for IFIT family in skin cutaneous melanoma. Int Immunopharmacol 101:108344","journal-title":"Int Immunopharmacol"},{"key":"1960_CR72","doi-asserted-by":"crossref","first-page":"758288","DOI":"10.3389\/fimmu.2021.758288","volume":"12","author":"M Yan","year":"2021","unstructured":"Yan M, Hu J, Ping Y, Xu L, Liao G, Jiang Z, Pang B, Sun S, Zhang Y, Xiao Y, Li X (2021) Single-Cell Transcriptomic Analysis Reveals a Tumor-Reactive T Cell Signature Associated With Clinical Outcome and Immunotherapy Response In Melanoma. Front Immunol 12:758288","journal-title":"Front Immunol"},{"key":"1960_CR73","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40246-021-00350-3","volume":"15","author":"E Zhang","year":"2021","unstructured":"Zhang E, Chen Y, Bao S, Hou X, Hu J, Mu OYN, Song Y, Shan L (2021) Identification of subgroups along the glycolysis-cholesterol synthesis axis and the development of an associated prognostic risk model. Hum Genomics 15:53","journal-title":"Hum Genomics"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-024-01960-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-024-01960-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-024-01960-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:03:52Z","timestamp":1721693032000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-024-01960-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,14]]},"references-count":73,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["1960"],"URL":"https:\/\/doi.org\/10.1007\/s10495-024-01960-7","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,14]]},"assertion":[{"value":"13 March 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The protocol for collecting human tissue samples was approved by the Ethics Committee of the the Second Affiliated Hospital of Nanchang University, and all procedures were performed in accordance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Written informed consent was provided by all participants before their inclusion in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All individuals were informed about the purposes of the study and have signed their consent for publishing the data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}